Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide

  1. Martínez-López, J.
  2. Rivero, A.
  3. Rapado, I.
  4. Montalbán, C.
  5. Paz-Carreira, J.
  6. Canales, M.
  7. Martínez, R.
  8. Sánchez-Godoy, P.
  9. Fernández De Sevilla, A.
  10. Peñalver, F.J.
  11. Gonzalez, M.
  12. Prieto, E.
  13. Salar, A.
  14. Burgaleta, C.
  15. Queizán, J.A.
  16. Peñarrubia, M.J.
  17. Monteagudo, M.D.
  18. Cabrera, C.
  19. De La Serna, J.
  20. Tomás, J.F.
Aldizkaria:
Leukemia and Lymphoma

ISSN: 1042-8194 1029-2403

Argitalpen urtea: 2009

Alea: 50

Zenbakia: 8

Orrialdeak: 1283-1289

Mota: Artikulua

DOI: 10.1080/10428190903040006 GOOGLE SCHOLAR